Saturday, November 21, 2026
Science
No Result
View All Result
  • Login
  • HOME
  • SCIENCE NEWS
  • CONTACT US
  • HOME
  • SCIENCE NEWS
  • CONTACT US
No Result
View All Result
Scienmag
No Result
View All Result
Home Science News Medicine

Doctors Prefer Single Pneumococcal Vaccine Unless Coverage Gap Is Large

November 20, 2026
in Medicine
Kristina Jarvis
By Kristina Jarvis Scienmag Editorial Profile - Infectious Disease Medicine
Reading Time: 6 mins read
0
Doctors Prefer Single Pneumococcal Vaccine Unless Coverage Gap Is Large

Doctors Prefer Single Pneumococcal Vaccine Unless Coverage Gap Is Large

65
SHARES
587
VIEWS
Share on FacebookShare on Twitter
ADVERTISEMENT

In a multinational survey of 500 healthcare professionals, a significant majority indicated that using a single pneumococcal vaccine for both children and adults is preferable to managing separate age-specific products, provided that the adult-specific vaccine does not offer a substantial advantage in serotype coverage. The study, published in Infectious Diseases and Therapy, reveals that practical implementation constraints, such as inventory management and storage requirements, heavily influence vaccine selection decisions alongside traditional clinical attributes like safety and effectiveness. This cross-sectional research highlights a critical tension in modern immunization strategies: the balance between maximizing disease coverage and maintaining operational simplicity in healthcare settings that serve diverse patient populations.

The research team, led by Jeffrey T. Vietri, Sophie A. Warren, and Matthew J. Heffler, designed the study to assess how healthcare professionals (HCPs) navigate the increasingly complex landscape of pneumococcal vaccines. Pneumococcal disease remains a major cause of morbidity and mortality worldwide, with clinical manifestations ranging from non-invasive infections like pneumonia to severe invasive pneumococcal disease (IPD), which includes bacteremia and meningitis. While clinical guidelines have evolved to include multiple vaccine types with varying serotype compositions, the operational burden of managing these diverse products has received less attention in preference studies, which have historically focused on clinical attributes or single-country contexts.

The survey was conducted between April and May 2025 and included 500 HCPs from Australia, Canada, France, Mexico, and Taiwan. The sample comprised 100 respondents from each country, ensuring a balanced multinational perspective. Participants included primary care physicians, pediatricians, pharmacists, and immunization or public health nurses who were actively involved in pneumococcal vaccination decision-making. To ensure relevance, respondents were required to have between three and 30 years of clinical experience and spend at least 75% of their professional time in direct patient care. The sample was slightly male-dominated at 54.8%, with the largest age group being 35 to 44 years, representing 41.6% of participants.

When asked about the importance of pneumococcal vaccination, the results were overwhelmingly positive. Ninety-seven point six percent of HCPs rated vaccination as important for children, while 99.2% rated it as important for adults. This high level of consensus underscores the recognized public health value of pneumococcal immunization across the life course. However, the study also found that HCPs prioritize specific attributes when selecting which vaccine to administer. Clinical effectiveness and safety were rated as the most important considerations, with 97.6% of respondents citing a proven track record of effectiveness and safety as a key factor. Availability of clinical effectiveness data and coverage against community-acquired pneumonia were also highly valued, rated as very important by 96.2% and 96.0% of HCPs, respectively.

Despite the emphasis on clinical attributes, logistical and operational factors played a significant role in vaccine selection. Among the 430 HCPs involved in vaccine logistics and operational decision-making, 94.0% identified fewer logistical hurdles in ordering and stocking as an important attribute. Ease of reimbursement was cited by 92.3% of these respondents, and minimal storage space requirements were considered important by 84.4%. These findings suggest that the physical and administrative burden of managing multiple vaccine products is a substantial consideration for providers. The study noted that medical doctors in France were excluded from logistical items because they rely on pharmacists for vaccine stocking, highlighting variations in healthcare delivery models across the participating countries.

The operational challenges of using separate pediatric and adult vaccines were clearly articulated by the respondents. Among those involved in logistics, 90.0% agreed that using two separate vaccines increases refrigeration space requirements. Similarly, 89.1% cited greater complexity in stock handling, and 86.7% noted increased inventory management complexity during vaccination campaigns. These logistical burdens are not merely administrative inconveniences; they can contribute to missed vaccination opportunities and increased decision-making burden for providers. The study links these operational complexities to broader implementation challenges seen in other vaccination programs, such as influenza and HPV, where complex schedules and multiple products have been associated with reduced efficiency.

In contrast, HCPs perceived several benefits associated with a single-vaccine strategy across age groups. The most significant perceived advantage was the potential for cost savings, with 85.1% of those involved in logistics agreeing that a single vaccine would provide practice-level cost savings. At the overall HCP sample level, 83.4% agreed that this approach would offer health system-level cost savings. Furthermore, 96.3% of HCPs involved in logistics agreed that a single vaccine would reduce the potential for medical errors. This concern is supported by previous research indicating that age-related errors, such as administering the wrong vaccine or dose, account for a significant proportion of non-COVID vaccine errors. Ease of inventory management was also highly valued, with 93.0% of respondents agreeing that a single vaccine would simplify this process.

A central finding of the study was the threshold of serotype coverage difference required to justify the use of separate vaccines. HCPs were asked to estimate the relative increase in IPD coverage that would make them consider adding an adult-specific vaccine to their existing pediatric vaccine. On average, respondents indicated that a difference of 34.7% (standard deviation 16.8%) in adult-specific IPD serotype coverage would be necessary to justify a shift away from a single-vaccine approach. This threshold is notably higher than the incremental serotype coverage differences typically reported between higher-valent adult pneumococcal vaccines in recent epidemiological analyses. This suggests that unless an adult-specific vaccine offers a substantial coverage advantage, HCPs are likely to prefer the operational simplicity of a single product.

The study also explored the potential communication benefits of a single-vaccine strategy. A majority of HCPs, 69.2%, agreed that a vaccine approved for both pediatric and adult use could increase acceptance among vaccine-hesitant adults. Additionally, 59.4% of respondents reported being more comfortable administering a vaccine to adults if it also had pediatric approval. These findings point to a potential pathway for improving adult vaccination uptake by leveraging familiarity with vaccines already used in pediatric care. However, there was some variation in opinion, with approximately one-third of respondents disagreeing with the statement that two vaccines increase the risk of medical errors, and 40% disagreeing with the comfort level associated with dual-approved vaccines.

The authors acknowledge several limitations of the study. The cross-sectional design and reliance on self-reported perceptions mean that the findings reflect attitudes at a specific point in time rather than actual prescribing behavior. The sample was drawn primarily from urban areas, which may limit the generalizability of the results to rural or lower-resource settings facing greater implementation challenges. Furthermore, the descriptive nature of the analyses precludes inferential statistical comparisons across countries or HCP subgroups. The study did not measure medical error rates or directly observe workflows, so the perceived benefits of a single-vaccine strategy remain hypothetical in terms of actual clinical outcomes.

Despite these limitations, the study provides valuable insights into the practical considerations that shape pneumococcal vaccine selection. The findings suggest that policymakers and health systems should consider implementation feasibility alongside clinical and epidemiological evidence when evaluating vaccination strategies. By understanding the operational burdens associated with multiple vaccine products, stakeholders can design strategies that support sustainable delivery in routine practice. The preference for single-vaccine strategies, unless accompanied by a substantial coverage advantage, highlights the need for vaccines that balance broad serotype coverage with logistical simplicity.

The evolving landscape of pneumococcal vaccines, with the introduction of higher-valent conjugate vaccines and changing serotype dynamics, continues to present challenges for healthcare providers. Post-COVID serotype dynamics have altered the distribution of circulating strains in several regions, making accurate characterization of local IPD epidemiology essential. In this context, the ability to use a single vaccine across age groups may offer a practical approach to simplifying vaccine delivery while maintaining high standards of care. The study’s emphasis on the interplay between clinical attributes and operational feasibility underscores the complexity of modern immunization programs and the need for holistic approaches to vaccine selection.

As vaccination schedules expand and more vaccines are introduced for adult populations, the cognitive and logistical challenges for providers will likely increase. The findings from this multinational survey indicate that HCPs are keenly aware of these challenges and are actively seeking ways to streamline their practices. The preference for single-vaccine strategies, driven by concerns over inventory management, storage, and medical errors, suggests that future vaccine development and policy recommendations should prioritize operational simplicity. By aligning clinical goals with practical realities, health systems can improve vaccine uptake and ensure that the benefits of pneumococcal vaccination are realized for both children and adults.

In conclusion, this study demonstrates that healthcare professionals weigh practical implementation factors heavily when selecting pneumococcal vaccines. While clinical attributes remain foundational, the operational burden of managing multiple vaccines is a significant consideration. The threshold of 34.7% in serotype coverage difference required to justify separate vaccines provides a concrete metric for evaluating the value of adult-specific vaccines. These insights are crucial for policymakers and health system planners as they navigate the complexities of modern immunization programs and strive to optimize vaccine delivery in diverse healthcare settings.

Subject of Research: Multinational survey of healthcare professional preferences and practical considerations in pneumococcal vaccine selection

Article Title: Practical Considerations Shaping Pneumococcal Vaccine Selection: A Multinational Cross-Sectional Survey of Healthcare Professionals

Article References: Vietri, J. T., Warren, S. A., & Heffler, M. J. (2026). Practical Considerations Shaping Pneumococcal Vaccine Selection: A Multinational Cross-Sectional Survey of Healthcare Professionals. Infectious Diseases and Therapy, 15(11), 3003-3015. https://doi.org/10.1007/s40121-026-01436-y

Image Credits: AI Generated

DOI: 10.1007/s40121-026-01436-y

Keywords: pneumococcal vaccine, healthcare professionals, vaccine selection, cross-sectional survey, serotype coverage, inventory management, vaccine logistics, invasive pneumococcal disease, clinical practice, vaccine implementation, multinational study, immunization strategy, operational complexity, medical errors, vaccine hesitancy, adult vaccination, pediatric vaccination, health policy, vaccine storage, clinical attributes

Cite Scienmag News

Kristina Jarvis. (November 20, 2026). Doctors Prefer Single Pneumococcal Vaccine Unless Coverage Gap Is Large. Scienmag. https://scienmag.com/doctors-prefer-single-pneumococcal-vaccine-unless-coverage-gap-is-large/

Kristina Jarvis. "Doctors Prefer Single Pneumococcal Vaccine Unless Coverage Gap Is Large." Scienmag, 20 November 2026, https://scienmag.com/doctors-prefer-single-pneumococcal-vaccine-unless-coverage-gap-is-large/. Accessed 21 November 2026.

Kristina Jarvis. "Doctors Prefer Single Pneumococcal Vaccine Unless Coverage Gap Is Large." Scienmag. November 20, 2026. https://scienmag.com/doctors-prefer-single-pneumococcal-vaccine-unless-coverage-gap-is-large/

Tags: adult vaccinationclinical attributesclinical practicecross-sectional surveyhealth policyhealthcare professionalsImmunization StrategyInvasive Pneumococcal Diseaseinventory managementmedical errorsmultinational studyoperational complexitypediatric vaccinationpneumococcal vaccineserotype coveragevaccine hesitancyvaccine implementationvaccine logisticsvaccine selectionvaccine storage
Share26Tweet16
Previous Post

Bayesian Fusion-Net Reduces Image Fusion Compute to 0.07G FLOPs

Next Post

Preoperative Nomogram Combines ALBI and Body Composition to Predict Liver Failure

Related Posts

Nigerian Study Finds Newborn Vitamin D Levels Systematically Trail Maternal Concentrations
Medicine

Nigerian Study Finds Newborn Vitamin D Levels Systematically Trail Maternal Concentrations

November 21, 2026
Progranulin Review Highlights Lysosomal Failure as Central Driver in Neurodegenerative Diseases
Medicine

Progranulin Review Highlights Lysosomal Failure as Central Driver in Neurodegenerative Diseases

November 21, 2026
Normalization Drives Underreporting of Biological Hazards in Surgical Operating Rooms
Medicine

Normalization Drives Underreporting of Biological Hazards in Surgical Operating Rooms

November 21, 2026
Systematic Review Details Global Patterns and Clinical Presentation of Intestinal Capillariasis
Medicine

Systematic Review Details Global Patterns and Clinical Presentation of Intestinal Capillariasis

November 21, 2026
Bed Net Knowledge Outpaces Use Among HIV Patients in Northwest Ethiopia
Medicine

Bed Net Knowledge Outpaces Use Among HIV Patients in Northwest Ethiopia

November 21, 2026
Adult Oral Health Links to Key Psychosocial Assets in Global Scoping Review
Medicine

Adult Oral Health Links to Key Psychosocial Assets in Global Scoping Review

November 21, 2026
Next Post
Preoperative Nomogram Combines ALBI and Body Composition to Predict Liver Failure

Preoperative Nomogram Combines ALBI and Body Composition to Predict Liver Failure

  • Mothers who receive childcare support from maternal grandparents show more optimized

    Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study

    27656 shares
    Share 11059 Tweet 6912
  • University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept

    1061 shares
    Share 424 Tweet 265
  • Bee body mass, pathogens and local climate influence heat tolerance

    682 shares
    Share 273 Tweet 171
  • Researchers record first-ever images and data of a shark experiencing a boat strike

    546 shares
    Share 218 Tweet 137
  • Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function

    531 shares
    Share 212 Tweet 133
Science

Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!

RECENT NEWS

  • Nigerian Study Finds Newborn Vitamin D Levels Systematically Trail Maternal Concentrations
  • Molecular Review Identifies Genetic Networks Directing Cotton Somatic Embryogenesis and Transformation
  • Progranulin Review Highlights Lysosomal Failure as Central Driver in Neurodegenerative Diseases
  • Tanzanian Technical Audit Study Identifies Key Governance Factors and Performance Gaps

Categories

  • Agriculture
  • Anthropology
  • Archaeology
  • Athmospheric
  • Biology
  • Biotechnology
  • Blog
  • Bussines
  • Cancer
  • Chemistry
  • Climate
  • Earth Science
  • Editorial Policy
  • Marine
  • Mathematics
  • Medicine
  • Pediatry
  • Policy
  • Psychology & Psychiatry
  • Science Education
  • Science News
  • Social Science
  • Space
  • Technology and Engineering

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 5,151 other subscribers

© 2026 Scienmag - Science Magazine

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • HOME
  • SCIENCE NEWS
  • CONTACT US

© 2026 Scienmag - Science Magazine

Discover more from Science

Subscribe now to keep reading and get access to the full archive.

Continue reading